anatabine

nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 ; Mus musculus







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33846461 A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau mice. 2021 Apr 12 1
2 26010758 Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD. 2015 1